Disc Medicine IRON Unrealized gains (losses) on available-for-sale securities
Unrealized gains (losses) on available-for-sale securities at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax.
The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Disc Medicine's unrealized gains (losses) on available-for-sale securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Disc Medicine's unrealized gains (losses) on available-for-sale securities?
- Disc Medicine (IRON) reported unrealized gains (losses) on available-for-sale securities of -$1.53M in Q1 2026.
- How has Disc Medicine's unrealized gains (losses) on available-for-sale securities changed year-over-year?
- Disc Medicine's unrealized gains (losses) on available-for-sale securities decreased by 757.8% year-over-year, from $232K to -$1.53M.
- What does unrealized gains (losses) on available-for-sale securities mean?
- This metric captures the change in the fair value of investment securities classified as available-for-sale that has not yet been realized through a sale. It reflects unrealized market-to-market adjustments that bypass the income statement but impact the company's total equity. This provides insight into the performance and volatility of the company's treasury or investment portfolio.